• Factors ID’d for Strong Antibody Response in COVID-19

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • COVID-19 Pandemic Challenges Osteoporosis Management

    Healthday News COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 26, 2020
  • Survival From COVID-19 High in Patients With Psoriasis

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy October 23, 2020
  • FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 23, 2020

Sponsored by Janssen Pharmaceuticals, Inc. Intended for Healthcare Professionals

covid19.healthcare.pro
Navigation
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
Home Articles THER

Tag Archive

  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    Factors ID’d for Strong Antibody Response in COVID-19

    View Post
  • COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    COVID-19 Pandemic Challenges Osteoporosis Management

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 26, 2020

    AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy / October 23, 2020

    Survival From COVID-19 High in Patients With Psoriasis

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 23, 2020

    FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    View Post
View Post

COVID-19 Antibody Treatments Exceed Expectations in Early Trials

In COVID-19, Latest News
by Healthday
January 27, 2021

Eli Lilly and Regeneron asking regulators to expand authorization of their drugs based on the new findings

View Post

IgG Level in Convalescent Plasma Affects COVID-19 Death Risk

In COVID-19, Latest News
by Healthday
January 19, 2021

Risk for death reduced with higher versus lower levels of anti-SARS-CoV-2 IgG, but only in patients not receiving mechanical ventilation

View Post

Early High-Titer Plasma Reduces Progression of COVID-19

In COVID-19, Latest News
by Healthday
January 8, 2021

Early administration of high-titer convalescent plasma against SARS-CoV-2 reduces progression in mildly ill older adults

View Post

Red Cross Issues Call for More Blood Plasma to Treat COVID-19 Patients

In COVID-19, Latest News
by Healthday
January 7, 2021

People who have recovered from COVID-19 may have antibodies in their plasma that could boost immunity in current patients

View Post

COVID-19 Outcomes Not Improved With Convalescent Plasma

In COVID-19, Latest News
by Healthday
November 30, 2020

Clinical status, mortality did not differ for convalescent plasma versus placebo in adults with severe COVID-19 pneumonia

View Post

Nebulized Interferon Beta-1a Promising for COVID-19

In COVID-19, Latest News
by Healthday
November 17, 2020

Adults hospitalized for COVID-19 receiving SNG001 versus placebo more likely to show clinical improvement

View Post

Convalescent Plasma Has Limited Benefit for Moderate COVID-19

In COVID-19, Critical Care, Emergency Medicine, HealthDay News, Hematology & Oncology, Latest News, Pharmacy
by Healthday
October 23, 2020

Randomized phase II trial shows no drop in progression to severe disease, all-cause deaths

TRENDING

  • Thousands of Airport Screeners Needed in the USA
  • Risk Reduced for Positive NAAT Result With SARS-CoV-2 Antibodies
  • U.S. FDA Issues New Guidance to Medical Product Developers Addressing Virus Variants
  • Ebola Vaccinations Launch in Western Africa
  • Children Given Flu Shot Less Likely to Have Symptomatic COVID-19

By Publish Date

February 2021
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
« Jan    

LATEST ARTICLES

  • Thousands of Airport Screeners Needed in the USA February 25, 2021
  • Risk Reduced for Positive NAAT Result With SARS-CoV-2 Antibodies February 25, 2021
  • U.S. FDA Issues New Guidance to Medical Product Developers Addressing Virus Variants February 24, 2021

Sponsored by Janssen Pharmaceuticals, Inc. Intended for U.S. Healthcare Professionals.

Powered by eHealthcare Solutions. | Privacy Policy

  • COVID-19
  • Travel Vaccine News
  • Family Practice
  • OBGYN & Women’s Health
  • Clinical Guidelines